Sunshine Biopharma (SBFM) Sunshine Biopharma closed its previously announced public offering with gross proceeds to the company of around $6.0 million, the company said Friday.
The offering consisted of 10.9 million common units or pre-funded units, with each consisting of a share or pre-funded warrant and two warrants to purchase a share at an initial exercise price of $0.66, the company said.
The public offering was $0.55 per share, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments